Get the Stockscreener App
37.52
7.38%
-2.99
Bruker Corp stock is traded at $37.52, with a volume of 4.15M.
It is down -7.38% in the last 24 hours and down -8.91% over the past month.
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
See More
Previous Close:
$40.51
Open:
$41.01
24h Volume:
4.15M
Relative Volume:
1.82
Market Cap:
$6.13B
Revenue:
$3.24B
Net Income/Loss:
$304.90M
P/E Ratio:
18.04
EPS:
2.08
Net Cash Flow:
$156.70M
1W Performance:
-7.22%
1M Performance:
-8.91%
6M Performance:
-35.01%
1Y Performance:
-50.77%
1-Day Range:
$37.49
$41.25
1-Week Range:
$37.49
$43.09
52-Week Range:
$34.10
$79.78
Bruker Corp Stock (BRKR) Company Profile
Name
Bruker Corp
Sector
Industry
Phone
978663-3660
Address
40 MANNING RD, BILLERICA, MA
Compare BRKR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
37.52 | 6.13B | 3.24B | 304.90M | 156.70M | 2.08 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-10-24 | Initiated | UBS | Neutral |
| Dec-05-24 | Upgrade | Goldman | Sell → Neutral |
| Oct-15-24 | Initiated | Barclays | Overweight |
| Sep-30-24 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Feb-14-24 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-19-23 | Initiated | Wells Fargo | Equal Weight |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-21-22 | Initiated | UBS | Buy |
| Aug-22-22 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Market Perform |
| Jun-15-21 | Upgrade | Cleveland Research | Neutral → Buy |
| Feb-05-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-02-20 | Initiated | Goldman | Sell |
| Nov-16-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| May-01-20 | Downgrade | Cleveland Research | Buy → Neutral |
| Apr-02-20 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Apr-01-20 | Downgrade | Needham | Strong Buy → Hold |
| Mar-26-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Hold |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Upgrade | Goldman | Sell → Neutral |
| Jun-24-19 | Reiterated | Needham | Strong Buy |
| Jun-21-19 | Reiterated | BofA/Merrill | Neutral |
| May-30-19 | Initiated | Wolfe Research | Peer Perform |
| May-06-19 | Reiterated | Needham | Strong Buy |
| May-03-19 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| May-03-19 | Upgrade | UBS | Sell → Neutral |
| Apr-12-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-19 | Reiterated | BTIG Research | Buy |
| Jan-03-19 | Initiated | Needham | Strong Buy |
View All
Bruker Corp Stock (BRKR) Latest News
Bruker Corporation (BRKR): A Bull Case Theory - MSN
Bruker Corporation (NASDAQ:BRKR) Q1 2025 Earnings Call Transcript - Insider Monkey
Stifel cuts Bruker stock price target to $48, maintains hold By Investing.com - Investing.com Canada
Bruker (BRKR) Sees Price Target Lowered to $45 by UBS | BRKR Stock News - GuruFocus
Bruker (BRKR): Barclays Maintains Rating but Lowers Price Target - GuruFocus
Bruker (BRKR): Barclays Maintains Rating but Lowers Price Target | BRKR Stock News - GuruFocus
Bruker (BRKR) Target Price Lowered by Goldman Sachs | BRKR Stock News - GuruFocus
Stifel cuts Bruker stock price target to $48, maintains hold - Investing.com
UBS Reduces Price Target for Bruker (BRKR) Amid Funding and Tariff Concerns | BRKR Stock News - GuruFocus
Bruker (BRKR) Stock Target Price Lowered by Stifel Analyst | BRKR Stock News - GuruFocus
Bruker (BRKR) Price Target Reduced by Stifel Amid Flat Growth Outlook | BRKR Stock News - GuruFocus
Barclays Adjusts Price Target for Bruker (BRKR), Maintains Overweight Rating | BRKR Stock News - GuruFocus
Bruker: Q1 Earnings Snapshot - New Haven Register
Bruker Corp (BRKR) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges - Yahoo Finance
Earnings call transcript: Bruker Q1 2025 beats EPS, revenue forecasts - Investing.com
Compared to Estimates, Bruker (BRKR) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Bruker (BRKR) Increases FY25 Revenue Forecast | BRKR Stock News - GuruFocus
Bruker (BRKR) Surpasses Q1 Revenue Expectations with Key Product Launches | BRKR Stock News - GuruFocus
Bruker’s (NASDAQ:BRKR) Q1 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations - Yahoo Finance
Bruker earnings beat by $0.05, revenue topped estimates - Investing.com
Bruker Corp Q1 2025 Earnings: Revenue Surpasses Estimates at $801.4 Million, GAAP EPS Falls Short at $0.11 - GuruFocus
Bruker reports Q1 beat, lowers FY2025 guidance on market headwinds By Investing.com - Investing.com Canada
Bruker Reports First Quarter 2025 Financial Results - Stock Titan
Nanorobots Market Size to Exceed USD 38,660 Million by 2034, Rising Demand for Targeted Drug Delivery is Driving Market Growth. - GlobeNewswire Inc.
Bruker announces majority acquisition of RECIPE, a leading provider of mass spectrometry-based diagnostic assay kits for therapeutic drug monitoring - Select Science
Press Release Distribution & PR Platform - ACCESS Newswire
Bruker to launch Beacon Discovery at AACR 2025, expanding access to live single-cell functional analysis - Select Science
Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025 – Company Announcement - Financial Times
Bruker Spatial Biology Pushes Boundaries in Spatial Biology and Multiomics at AACR 2025 - Stock Titan
Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis - Financial Times
Bruker Corporation (BRKR): Among Mid-Cap Stocks Insiders Were Buying in Q1 2025 - Insider Monkey
A Glimpse Into The Expert Outlook On Bruker Through 6 Analysts - Benzinga
Bruker to invest in German company RECIPE - Yahoo Finance
Bruker Introduces nVista 2P Miniature Microscope - Quantisnow
Bruker Introduces nVista 2P Miniature Microscope – Company Announcement - Financial Times
BRUKER CORP : Results of Operations and Financial Condition, Regulation FD Disclosure (form 8-K) - marketscreener.com
Bruker (BRKR) Acquires Majority Stake in RECIPE Chemicals + Instruments | BRKR Stock News - GuruFocus
Bruker Announces Majority Acquisition of RECIPE, a Leading Provider of Mass Spectrometry-based Diagnostic Assay Kits for Therapeutic Drug Monitoring - Yahoo Finance
Bruker's Strategic Move: $15M Revenue Diagnostics Firm RECIPE Acquisition Boosts Testing Portfolio - Stock Titan
Bruker Corp (BRKR) Shares Gap Down to $38.565 on Apr 15 - GuruFocus
Bruker Stock May Benefit Following Its Investment in Ridom GmbH - Yahoo Finance
Bruker (BRKR) Projects Revenue Growth Amid Mixed Segment Performance | BRKR Stock News - GuruFocus
Form DEF 14A BRUKER CORP For: May 29 - StreetInsider
Why Is Life Science Focused Bruker Stock Trading Higher On Friday?Bruker (NASDAQ:BRKR) - Benzinga
Bruker Debuts Fourier 80 Multinuclear Benchtop FT-NMR: Stock to Gain? - Yahoo Finance
Bruker Crushes Q1 Revenue Estimates: Double-Digit Growth Signals Strong Performance - Stock Titan
Bruker Complements Fast, Cost-effective IR Biotyper® Hospital Hygiene Testing and HAI Tracing with NGS Reflex Testing – Company AnnouncementFT.com - Financial Times
Bruker Launches FoodScreener Module for Comprehensive NMR-based Profiling of Honey - Global Food Industry News
Is Now An Opportune Moment To Examine Bruker Corporation (NASDAQ:BRKR)? - Yahoo Finance
Bruker Announces Groundbreaking 1.3 GHz NMR System, Stock Up - Nasdaq
Bruker unveils world’s first 1.3 GHz NMR spectrometer - Investing.com
Bruker Corp Stock (BRKR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):